TC BIOPHARM HOLDINGS PLC's ticker is and the CUSIP is 87807D111. A total of 8 filers reported holding TC BIOPHARM HOLDINGS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | -50.0% | 470,588 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $20 | -69.7% | 470,588 | 0.0% | 0.00% | -55.6% |
| Q4 2022 | $66 | -99.9% | 470,588 | 0.0% | 0.01% | -30.8% |
| Q3 2022 | $109,000 | +14.7% | 470,588 | 0.0% | 0.01% | +44.4% |
| Q2 2022 | $95,000 | -58.9% | 470,588 | 0.0% | 0.01% | -47.1% |
| Q1 2022 | $231,000 | – | 470,588 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 235,294 | $23,506 | 0.00% |
| Altium Capital Management LP | 18,823 | $1,880 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,174 | $1,410 | 0.00% |
| ARMISTICE CAPITAL, LLC | 37,648 | $3,761 | 0.00% |
| UBS Group AG | 200 | $20 | 0.00% |